HudsonAlpha Journal - 2010, Volume 2, Issue 7
July 8, 2010
ALS, also known as Lou Gehrig's disease, is one of the neurological diseases HudsonAlpha scientists are studying. The institute recently hosted an ALS workshop to discuss advances in research pertaining to this devastating disease. Read more.
BioTrain interns are making the grade this summer
BioTrain summer interns are halfway through the 2010 session. While they spend a lot of time in the labs, their educational experiences go beyond biotech. Read more.
More than 70 people have signed on to be HudsonAlpha volunteers. The team of "Partners in Progress" continues to grow seven months after we kicked off the program. Read more.
Khursheed Anwer is the president of EGEN, Inc., a HudsonAlpha associate company specializing in cancer therapies. He values the research and collaborative spirit found across the institute and shares his reasons for supporting HudsonAlpha.